Representative Dina Titus of Nevada, co-chair of the Congressional Cannabis Caucus, is calling on the new head of the Office of National Drug Control Policy to support full federal legalization of marijuana. Her message is simple: if the evidence has changed, federal policy should change with it.
The appeal comes as the administration moves toward reclassifying marijuana under federal law, shifting it from the most restrictive category to one that formally recognizes medical value. While that step would mark meaningful progress, Titus and other reform advocates argue it still falls short of what science—and the public—now support.
Titus is also backing legislation aimed at removing a long-standing federal rule that prevents the drug policy office from advocating for the legalization of substances currently listed as most dangerous under federal law. In practice, the restriction has limited the office’s ability to engage honestly with research findings on cannabis.
The new drug czar has expressed openness to medical marijuana and acknowledged that legalization is not inherently harmful, though she has stopped short of endorsing full recreational legalization. That position, while cautious, reflects the broader tension in Washington between incremental reform and comprehensive change.
For reform advocates, the moment feels overdue. With most states allowing some form of legal marijuana use, they argue federal policy is increasingly disconnected from both science and lived experience.
Whether this push leads to sweeping reform or another round of cautious steps remains uncertain. But one thing is clear: the conversation around marijuana in Washington is no longer about fear—it’s about facts, and whether policymakers are ready to fully catch up.
Dabbin-Dad Newsroom
If you liked this post, say thanks by sharing it
